Alosetron reduces time lost from work in women with diarrhoea-predominant irritable bowel syndrome: Data from phase III placebo-controlled clinical trials

Clinical Drug Investigation

Volumn 21, Issue 12, 2001, Pages 843-852

  Jhingran, Priti ^a   Decker, Chris ^a   Watson, Maria ^a   Northcutt, Allison ^a   Ricci, Jean Francois ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; SEROTONIN 3 ANTAGONIST;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; ECONOMIC ASPECT; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; PAIN; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; WORK DISABILITY;

EID: 0035692658     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121120-00007     Document Type: Article

References (17)

1. Irritable bowel syndrome: Definition, diagnosis, and epidemiology
2. Epidemiology of colonic symptoms and the irritable bowel syndrome
3. Irritable bowel syndrome in office-based practice in the United States
4. Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral
5. Medical costs in community subjects with irritable bowel syndrome
6. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom
7. Quality of life in irritable bowel syndrome, effect of therapy
8. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life
9. US Householder Survey of functional gastrointestinal disorders
10. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomized, placebo-controlled trial
11. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant IBS
12. Functional bowel disorders and functional abdominal pain
13. Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome
14. Sumatriptan injection reduces productivity loss during a migraine attack: Results of a double-blind, placebo-controlled trial
15. Review article: The safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients